Our Culture
February 6, 2021
Alnylam Named to Bloomberg's 2021 Gender-Equality Index
Alnylam has been selected to Bloomberg's Gender-Equality Index for 2021
Read More ›
November 20, 2020
6 in a Row! Alnylam Named a Boston Globe Top Place to Work for 2020
Alnylam has been named to The Boston Globe's Top Places to Work list for 2020, marking 6th years in a row.
Read More ›
June 24, 2020
Celebrating a Pride Month Unlike Any Other
We asked members of our SAGA (Sexuality and Gender Alliance) employee resource network (ERN) how they've been celebrating Pride this year, given the...
Read More ›
June 1, 2020
We Stand Against All Forms of Racism and Discrimination
On June 1, 2020, we issued the following public statement in response to events unfolding in the United States as a result of the killing of George Floyd...
Read More ›
May 12, 2020
Alnylam Named a Great Place to Work in the UK and Switzerland for Second Year in a Row
Alnylam has been recognized for the second year in a row as a Best Workplace 2020 in the UK and in Switzerland.
Read More ›
March 30, 2020
Alnylam's Response to COVID-19
Learn more about Alnylam's response to the COVID-19 pandemic.
Read More ›
February 19, 2020
Making Strides in Gender Parity
Alnylam ranked #3 in gender parity and #1 in fair representation for Women of Color (WOC) in Executive and Board Leadership among the top 25 employers in MA.
Read More ›
November 18, 2019
Alnylam Named a Boston Globe Top Place to Work for 5th Year in a Row
We're thrilled to be named a Top Places to Work for 2019 by The Boston Globe in the "Large Employer" category, marking our fifth year in a row on the list.
Read More ›
November 5, 2019
A Truly Special Place for Science
Recently, our company was named Science Magazine’s Top Employer for 2019 – a significant achievement in the scientific community and a true milestone...
Read More ›
October 25, 2019
Alnylam Named #1 Biopharma Employer by Science Magazine
Alnylam has been named the #1 science employer in biopharma for 2019 by Science Magazine and Science Careers. This is our first appearance on the list.
Read More ›
